Debt-to-equity in % of Mosaic ImmunoEngineering Inc. from Q1 2012 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Mosaic ImmunoEngineering Inc. quarterly Debt-to-equity history and change rate from Q1 2012 to Q3 2025.
  • Mosaic ImmunoEngineering Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -101%, a 0.01% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Mosaic ImmunoEngineering Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -101% -0.01% -0.01% 30 Sep 2025
Q2 2025 -101% +1.1% +1.1% 30 Jun 2025
Q1 2025 -101% +2.9% +2.8% 31 Mar 2025
Q4 2024 -101% +3.4% +3.3% 31 Dec 2024
Q3 2024 -101% +3.8% +3.6% 30 Sep 2024
Q2 2024 -102% +3.8% +3.6% 30 Jun 2024
Q1 2024 -104% +1.7% +1.6% 31 Mar 2024
Q4 2023 -104% +3.3% +3.1% 31 Dec 2023
Q3 2023 -105% +3.9% +3.6% 30 Sep 2023
Q2 2023 -106% +4.4% +4% 30 Jun 2023
Q1 2023 -106% +12% +9.9% 31 Mar 2023
Q4 2022 -108% +13% +11% 31 Dec 2022
Q3 2022 -109% +26% +19% 30 Sep 2022
Q2 2022 -111% +47% +30% 30 Jun 2022
Q1 2022 -117% +60% +34% 31 Mar 2022
Q4 2021 -121% +234% +66% 31 Dec 2021
Q3 2021 -135% -269% -201% 30 Sep 2021
Q2 2021 -158% -204% -441% 30 Jun 2021
Q1 2021 -177% -209% -655% 31 Mar 2021
Q4 2020 -355% -375% -1872% 31 Dec 2020
Q3 2020 134% +123% +1139% 31 Aug 2020
Q2 2020 46% +39% +539% 31 May 2020
Q1 2020 32% +27% +542% 29 Feb 2020
Q4 2019 20% +17% +536% 30 Nov 2019
Q3 2019 11% +7.8% +265% 31 Aug 2019
Q2 2019 7.2% +4.5% +164% 31 May 2019
Q1 2019 5% +2.7% +118% 28 Feb 2019
Q4 2018 3.2% +1.4% +77% 30 Nov 2018
Q3 2018 3% +1.3% +80% 31 Aug 2018
Q2 2018 2.7% +1.1% +69% 31 May 2018
Q1 2018 2.3% +0.54% +31% 28 Feb 2018
Q4 2017 1.8% +0.02% +1.1% 30 Nov 2017
Q3 2017 1.6% -0.18% -9.9% 31 Aug 2017
Q2 2017 1.6% -0.07% -4.1% 31 May 2017
Q1 2017 1.7% -0.34% -16% 28 Feb 2017
Q4 2016 1.8% -0.18% -9.3% 30 Nov 2016
Q3 2016 1.8% -1.1% -38% 31 Aug 2016
Q2 2016 1.7% -1.8% -51% 31 May 2016
Q1 2016 2.1% -1.7% -45% 29 Feb 2016
Q4 2015 1.9% -1.6% -46% 30 Nov 2015
Q3 2015 2.9% +0.29% +11% 31 Aug 2015
Q2 2015 3.4% +1.4% +69% 31 May 2015
Q1 2015 3.8% +1.9% +99% 28 Feb 2015
Q4 2014 3.6% -1.2% -25% 30 Nov 2014
Q3 2014 2.6% -2.1% -44% 31 Aug 2014
Q2 2014 2% -5.4% -73% 31 May 2014
Q1 2014 1.9% -8.7% -82% 28 Feb 2014
Q4 2013 4.8% -2.9% -38% 30 Nov 2013
Q3 2013 4.7% -2.8% -37% 31 Aug 2013
Q2 2013 7.5% +2.1% +40% 31 May 2013
Q1 2013 11% +7% +198% 28 Feb 2013
Q4 2012 7.7% 30 Nov 2012
Q3 2012 7.5% 31 Aug 2012
Q2 2012 5.3% 31 May 2012
Q1 2012 3.6% 29 Feb 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.